Discrimination between patients with different outcomes after an ACS was demonstrated for the first time using metabolic profiling technologies, which seem to be more accurate than the standard stratification based on clinical and biohumoral parameters.

Metabolomics by nuclear magnetic resonance identifies patients at high risk of death within two years after acute coronary syndrome / Grifoni, E; Vignoli, A; Tenori, L; Giusti, B; Takis, PG; Valente, S; Carrabba, N; Balzi, D; Barchielli, AM; Marchionni, N; Gensini, GF; Marcucci, R; Luchinat, C; Gori, AM. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - ELETTRONICO. - 38:(2017), pp. 786-786.

Metabolomics by nuclear magnetic resonance identifies patients at high risk of death within two years after acute coronary syndrome

Vignoli, A;Tenori, L;Giusti, B;Valente, S;Carrabba, N;Marchionni, N;Gensini, GF;Marcucci, R;Luchinat, C;Gori, AM
2017

Abstract

Discrimination between patients with different outcomes after an ACS was demonstrated for the first time using metabolic profiling technologies, which seem to be more accurate than the standard stratification based on clinical and biohumoral parameters.
2017
Goal 3: Good health and well-being for people
Grifoni, E; Vignoli, A; Tenori, L; Giusti, B; Takis, PG; Valente, S; Carrabba, N; Balzi, D; Barchielli, AM; Marchionni, N; Gensini, GF; Marcucci, R; L...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1208185
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact